Detailed Information

Cited 0 time in webofscience Cited 0 time in scopus
Metadata Downloads

Electromagnetic Low-Intensity Extracorporeal Shock Wave Therapy in Patients with Erectile Dysfunction: A Sham-Controlled, Double-Blind, Randomized Prospective Study

Authors
Kim, Kang SupJeong, Hyun CheolChoi, Sae WoongChoi, Yong SunCho, Hyuk JinHa, U-SynHong, Sung HooLee, Ji YoulLee, Seung WookAhn, Sun TaeMoon, Du GeonBae, Woong JinKim, Sae Woong
Issue Date
4월-2020
Publisher
PUSAN NATL UNIV MEDICAL SCH, DEPT UROLOGY
Keywords
Electromagnetic; Erectile dysfunction; Humans; Low-intensity extracorporeal shock wave therapy
Citation
WORLD JOURNAL OF MENS HEALTH, v.38, no.2, pp.236 - 242
Indexed
SCIE
SCOPUS
KCI
Journal Title
WORLD JOURNAL OF MENS HEALTH
Volume
38
Number
2
Start Page
236
End Page
242
URI
https://scholar.korea.ac.kr/handle/2021.sw.korea/56713
DOI
10.5534/wjmh.190130
ISSN
2287-4208
Abstract
Purpose: The aim of the present study was to evaluate the efficacy and safety of the electromagnetic-type low-intensity extracorporeal shock wave therapy (Li-ESWT) in patients with erectile dysfunction (ED). Materials and Methods: The randomized, sham-controlled, double-blind prospective study was performed at two referral hospitals. Participants were randomized in a 1:1 ratio to receive sham or Li-ESWT for 6 weeks. ED was evaluated at screening and at 4 and 7 weeks after treatment. Participants were asked to complete the international index of erectile function-erectile function (IIEF-EF) domain questionnaire, erection hardness scale (EHS), and sexual encounter profile questionnaire (SEPQ 2 and 3). !he development of complications was investigated. Results: Eighty-one of 96 patients completed the study. The median change in the IIEF-EF score in the Li-ESWT and sham groups was 5.1 and -2.2 (p<0.001), respectively, at the 7-week follow-up; 47.4% (18/38) patients had EHS <3, of which 77.8% (14/18) showed significant improvement in virtue of Li-ESWT treatment (p-0.001). A significant improvement was observed in the percentage of 'Yes" responses to SEPQ 2 and 3 in the Li-ESWI group vs. sham group from baseline to 7-week follow-up (91.3% vs. 69.4%; p-0.008 and 50.0% vs. 14.3%; p=0.002, respectively). No patients reported pain or other adverse events during treatment or follow-up. Conclusions: Thus, Li-ESWT could have a role in improving erectile function. Furthermore, it is safe. We believe that Li-ESWT is an attractive new treatment modality for patients with ED.
Files in This Item
There are no files associated with this item.
Appears in
Collections
College of Medicine > Department of Medical Science > 1. Journal Articles

qrcode

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.

Related Researcher

Researcher Moon, Du Geon photo

Moon, Du Geon
의과대학 (의학과)
Read more

Altmetrics

Total Views & Downloads

BROWSE